Review Article Preventive Medicine Pulmonology Miscellaneous
Does pharmacist-led medication review reduce surgical site infection in patients after cardiac surgery? A retrospective cohort study

Does pharmacist-led medication review reduce surgical site infection in patients after cardiac surgery? A retrospective cohort study

Authors

Omar Volkov

Omar Volkov

Mayo Clinic, Maldives

Adam Novak

Adam Novak

Mayo Clinic, Saint Helena

Corresponding

Published

December 6, 2025

Paper ID

PAP-000147

Status

Published

DOI

10.65712/tmj.test000405

Does pharmacist-led medication review reduce surgical site infection in patients after cardiac surgery? A retrospective cohort study

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of surgical site infection to health systems is substantial. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Effects were consistent across prespecified subgroups. surgical site infection occurred in 4% of the intervention group versus 17% of controls. Conclusion: Residual confounding cannot be excluded.

Introduction

Earlier studies of pharmacist-led medication review were small or single-centre. surgical site infection remains a leading cause of avoidable harm among patients after cardiac surgery.

The cost of surgical site infection to health systems is substantial. Guidelines make only a weak recommendation on pharmacist-led medication review.

Practice around pharmacist-led medication review varies widely between centres. Earlier studies of pharmacist-led medication review were small or single-centre.

Materials and Methods

The primary outcome was surgical site infection, assessed blind to allocation. Eligible participants were patients after cardiac surgery. Analyses were adjusted for age, sex and baseline severity.

Analyses were adjusted for age, sex and baseline severity. Eligible participants were patients after cardiac surgery. Missing data were handled with multiple imputation.

Missing data were handled with multiple imputation. Eligible participants were patients after cardiac surgery. We conducted a retrospective cohort study across 9 centres between 2017 and 2022.

Missing data were handled with multiple imputation. We conducted a retrospective cohort study across 5 centres between 2020 and 2025. We conducted a retrospective cohort study across 7 centres between 2020 and 2021.

Results

surgical site infection occurred in 4% of the intervention group versus 32% of controls. 3086 participants were included (median age 28 years). Effects were consistent across prespecified subgroups.

GroupnEvents
Centre A2454
Female63338
Intervention67036
Centre A88138
Age < 6586196
Intervention67945
Female14446
TABLE 1: Adverse events
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Distribution of surgical site infection
Shown for patients after cardiac surgery; error bars are 95% confidence intervals.

Serious adverse events were rare and similar between groups. surgical site infection occurred in 19% of the intervention group versus 13% of controls.

Discussion

Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.

Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.

Conclusions

Pharmacist-led medication review is a reasonable option for patients after cardiac surgery to improve surgical site infection.

References

1. Rossi R, Kim N, et al. Frailty screening and ventilator-free days. BMJ. 2016;76(2):503-1768.

2. Kim O, Kaur X, et al. Telemedicine follow-up and time to diagnosis. N Engl J Med. 2009;227(9):297-1607.

3. Zhang Q, Kowalski T, et al. Frailty screening and acute kidney injury. Crit Care Med. 2021;378(4):209-985.

4. Schmidt N, Kim Z, et al. A sepsis alert system and emergency department revisits. Lancet. 2023;106(8):120-1361.

5. Tanaka W, Kaur S, et al. Tranexamic acid and post-operative delirium. Diabetes Care. 2012;15(7):781-1199.

6. Yilmaz I, Nakamura Q, et al. Point-of-care ultrasound and ventilator-free days. BMJ. 2014;145(5):247-1282.

7. Farouk W, Farouk F, et al. Point-of-care ultrasound and emergency department revisits. Pediatrics. 2016;370(6):450-1120.

8. Andersen O, Lindqvist D, et al. Low-dose aspirin and ventilator-free days. Diabetes Care. 2024;180(7):214-1402.

9. Nasser M, Kaur K, et al. Pharmacist-led medication review and falls. Ann Intern Med. 2012;378(12):189-1277.

Appendices

Supplementary tables are available on request.